ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JIM MARTINEZ MD

6236 E PIMA ARIZONA COMMUNITY PHYSICIANS PC

Tucson | Arizona | 85712

(520) 327-6874

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 149 out of 1278

$510K Total Retail Price of All Prescriptions

Rank: 118 out of 1278

392 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,975 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 423 316 1 1
LEVOTHYROXINE SODIUM 353 247 2 2
HYDROCODONE-ACETAMINOPHEN 301 236 S3 3 7
AMLODIPINE BESYLATE 248 212 4 5
SIMVASTATIN 230 195 5 3
GABAPENTIN 224 157 6 12
METFORMIN HCL 174 125 7 4
METOPROLOL TARTRATE 161 134 8 9
HYDROCHLOROTHIAZIDE 152 104 9 8
MORPHINE SULFATE ER 148 22 S2 10 42
LOSARTAN POTASSIUM 143 118 11 19
WARFARIN SODIUM 130 117 12 17
OXYCODONE-ACETAMINOPHEN 123 70 S2 13 29
CYMBALTA 120 73 14 67
OMEPRAZOLE 102 72 15 6
ATENOLOL 101 75 16 11
TRAZODONE HCL 100 66 17 38
FUROSEMIDE 98 84 18 10
GLYBURIDE 94 70 R 19 40
PRAVASTATIN SODIUM 93 81 20 14
GLIPIZIDE 90 74 21 35
POTASSIUM CHLORIDE 90 83 21 21
JANUVIA 88 72 23 68
OXYCODONE HCL 87 22 S2 24 27
DONEPEZIL HCL 85 69 25 48
CITALOPRAM HBR 82 58 26 22
DOXAZOSIN MESYLATE 81 78 27 69
CARVEDILOL 78 67 28 39
OXYCONTIN 76 31 S2 29 89
IBUPROFEN 74 63 30 46
FLUOXETINE HCL 68 50 31 41
SINGULAIR 68 37 31 155
TRAMADOL HCL 66 37 33 25
SERTRALINE HCL 65 47 34 28
MORPHINE SULFATE 64 16 S2 35 115
ALLOPURINOL 63 50 36 36
CARISOPRODOL 60 21 R 37 51
AZITHROMYCIN 59 37 38 37
ALPRAZOLAM 58 37 39 231
CARTIA XT 56 49 40 247
RANITIDINE HCL 53 43 41 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.